Braidwell
Latest statistics and disclosures from Braidwell's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAI, Guardant Health, EWTX, Repligen Corp, NBIX, and represent 23.98% of Braidwell's stock portfolio.
- Added to shares of these 10 stocks: KOD (+$58M), CNTA (+$55M), BTSG (+$45M), NRIX (+$41M), ILMN (+$35M), CLDX (+$34M), NEO (+$34M), FULC (+$32M), MBX (+$32M), RAPT (+$32M).
- Started 20 new stock positions in KOD, BTSG, VTYX, KPTI, XFOR, CNTA, GLUE, RLMD, GRAL, BIIB. NRIX, EOLS, NTRA, ILMN, BLLN, MBX, ICLR, TERN, RAPT, CMPX.
- Reduced shares in these 10 stocks: Guardant Health (-$210M), Novocure (-$210M), XENE (-$80M), KRYS (-$79M), APGE (-$65M), CGON (-$59M), DHR (-$44M), ORKA (-$39M), ARGX (-$38M), Karyopharm Therapeutics (-$35M).
- Sold out of its positions in AKRO, ATEC, AMLX, Avidity Biosciences Ord, DAWN, Dexcom, EHC, EXACT Sciences Corporation, GMED, HTFL. Immunocore Hldgs, Karyopharm Therapeutics, Novocure, REPL, SRPT, SION, THC, RARE, VKTX, RPRX.
- Braidwell was a net seller of stock by $-758M.
- Braidwell has $3.1B in assets under management (AUM), dropping by -7.22%.
- Central Index Key (CIK): 0001920938
Tip: Access up to 7 years of quarterly data
Positions held by Braidwell consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Braidwell
Braidwell holds 73 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Caris Life Sciences (CAI) | 6.7 | $211M | +6% | 7.8M | 26.98 |
|
| Guardant Health Debt 1.250% 2/1 (Principal) | 6.2 | $192M | -52% | 105M | 1.83 |
|
| Edgewise Therapeutics (EWTX) | 4.1 | $129M | 5.2M | 24.82 |
|
|
| Repligen Corp Note 1.000%12/1 (Principal) | 3.5 | $111M | 101M | 1.10 |
|
|
| Neurocrine Biosciences (NBIX) | 3.4 | $107M | -14% | 752k | 141.83 |
|
| Glaukos (GKOS) | 3.3 | $104M | +18% | 922k | 112.91 |
|
| Neogenomics Note 0.250% 1/1 (Principal) | 2.9 | $90M | 100M | 0.89 |
|
|
| Nuvalent Inc-a (NUVL) | 2.6 | $83M | -18% | 821k | 100.59 |
|
| Xenon Pharmaceuticals (XENE) | 2.6 | $82M | -49% | 1.8M | 44.82 |
|
| Cg Oncology (CGON) | 2.5 | $78M | -43% | 1.9M | 41.52 |
|
| Irhythm Technologies Note 1.500% 9/0 (Principal) | 2.3 | $73M | -16% | 52M | 1.40 |
|
| Hinge Health Cl A (HNGE) | 1.9 | $61M | +43% | 1.3M | 46.45 |
|
| Align Technology (ALGN) | 1.9 | $60M | -7% | 381k | 156.15 |
|
| Kodiak Sciences (KOD) | 1.9 | $58M | NEW | 2.1M | 27.96 |
|
| Soleno Therapeutics (SLNO) | 1.8 | $55M | -7% | 1.2M | 46.30 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.8 | $55M | NEW | 2.2M | 25.01 |
|
| Neogenomics Com New (NEO) | 1.7 | $55M | +161% | 4.6M | 11.76 |
|
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $54M | -14% | 2.0M | 26.71 |
|
| Spyre Therapeutics Com New (SYRE) | 1.7 | $54M | -36% | 1.6M | 32.76 |
|
| Dianthus Therapeutics (DNTH) | 1.7 | $53M | +52% | 1.3M | 41.21 |
|
| Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal) | 1.6 | $51M | -34% | 53M | 0.94 |
|
| Celldex Therapeutics Com New (CLDX) | 1.6 | $51M | +214% | 1.9M | 27.16 |
|
| Inspire Med Sys (INSP) | 1.6 | $50M | -38% | 541k | 92.23 |
|
| Krystal Biotech (KRYS) | 1.6 | $50M | -61% | 202k | 246.54 |
|
| Intuitive Surgical Com New (ISRG) | 1.5 | $47M | -35% | 83k | 566.36 |
|
| Thermo Fisher Scientific (TMO) | 1.5 | $47M | -29% | 81k | 579.45 |
|
| Brightspring Health Svcs (BTSG) | 1.4 | $45M | NEW | 1.2M | 37.45 |
|
| CVS Caremark Corporation (CVS) | 1.4 | $45M | +28% | 564k | 79.36 |
|
| Apogee Therapeutics (APGE) | 1.4 | $43M | -60% | 575k | 75.48 |
|
| Nurix Therapeutics (NRIX) | 1.3 | $41M | NEW | 2.2M | 18.97 |
|
| Vera Therapeutics Cl A (VERA) | 1.3 | $40M | +65% | 785k | 50.64 |
|
| Irhythm Technologies (IRTC) | 1.2 | $39M | -3% | 217k | 177.44 |
|
| Transmedics Group (TMDX) | 1.2 | $38M | -10% | 315k | 121.65 |
|
| BioMarin Pharmaceutical (BMRN) | 1.1 | $36M | +13% | 602k | 59.43 |
|
| Illumina (ILMN) | 1.1 | $35M | NEW | 270k | 131.16 |
|
| Kymera Therapeutics (KYMR) | 1.1 | $35M | +64% | 454k | 77.81 |
|
| Fulcrum Therapeutics (FULC) | 1.1 | $35M | +1294% | 3.1M | 11.31 |
|
| Penumbra (PEN) | 1.1 | $34M | -22% | 110k | 310.91 |
|
| Mbx Biosciences (MBX) | 1.0 | $32M | NEW | 1.0M | 31.54 |
|
| Rapt Therapeutics Com New (RAPT) | 1.0 | $32M | NEW | 930k | 33.87 |
|
| Caredx (CDNA) | 1.0 | $30M | -27% | 1.6M | 18.84 |
|
| Dyne Therapeutics (DYN) | 0.9 | $29M | -45% | 1.5M | 19.56 |
|
| Engene Holdings (ENGN) | 0.9 | $28M | +38% | 3.1M | 9.03 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $28M | -28% | 1.3M | 21.74 |
|
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.9 | $27M | 8.4M | 3.25 |
|
|
| Danaher Corporation (DHR) | 0.9 | $27M | -61% | 118k | 228.92 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $26M | -59% | 31k | 840.95 |
|
| Natera (NTRA) | 0.8 | $26M | NEW | 112k | 229.09 |
|
| Bright Minds Biosciences Com New (DRUG) | 0.8 | $25M | +6% | 324k | 78.04 |
|
| Terns Pharmaceuticals (TERN) | 0.7 | $23M | NEW | 575k | 40.40 |
|
| Evolus (EOLS) | 0.7 | $21M | NEW | 3.1M | 6.65 |
|
| Biogen Idec (BIIB) | 0.7 | $20M | NEW | 116k | 175.99 |
|
| Orthopediatrics Corp. (KIDS) | 0.6 | $20M | 1.1M | 17.76 |
|
|
| Tectonic Therapeutic (TECX) | 0.6 | $19M | +25% | 928k | 20.86 |
|
| Ventyx Biosciences (VTYX) | 0.6 | $17M | NEW | 1.9M | 9.03 |
|
| Zura Bio Class A Ord Shs (ZURA) | 0.5 | $17M | +28% | 3.2M | 5.24 |
|
| Compass Therapeutics (CMPX) | 0.5 | $15M | NEW | 2.8M | 5.37 |
|
| Monte Rosa Therapeutics (GLUE) | 0.5 | $15M | NEW | 948k | 15.68 |
|
| Harrow Health (HROW) | 0.5 | $15M | -13% | 295k | 49.00 |
|
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $14M | NEW | 3.4M | 4.00 |
|
| Repligen Corporation (RGEN) | 0.4 | $13M | -58% | 82k | 163.86 |
|
| Icon SHS (ICLR) | 0.4 | $13M | NEW | 73k | 182.22 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.4 | $13M | -51% | 314k | 41.25 |
|
| Grail (GRAL) | 0.4 | $12M | NEW | 143k | 85.59 |
|
| Surrozen Com New (SRZN) | 0.3 | $11M | +235% | 470k | 22.60 |
|
| Relmada Therapeutics (RLMD) | 0.2 | $7.6M | NEW | 1.6M | 4.83 |
|
| Xencor (XNCR) | 0.2 | $7.0M | -63% | 459k | 15.31 |
|
| Castle Biosciences (CSTL) | 0.2 | $6.9M | -78% | 177k | 38.90 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $5.1M | -57% | 312k | 16.24 |
|
| Billiontoone Cl A (BLLN) | 0.1 | $4.1M | NEW | 50k | 81.84 |
|
| Oruka Therapeutics (ORKA) | 0.1 | $2.6M | -93% | 85k | 30.31 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $2.2M | NEW | 303k | 7.36 |
|
| Pulmonx Corp (LUNG) | 0.1 | $1.7M | 753k | 2.21 |
|
Past Filings by Braidwell
SEC 13F filings are viewable for Braidwell going back to 2022
- Braidwell 2025 Q4 filed Feb. 17, 2026
- Braidwell 2025 Q3 filed Nov. 14, 2025
- Braidwell 2025 Q2 filed Aug. 14, 2025
- Braidwell 2025 Q1 filed May 15, 2025
- Braidwell 2024 Q4 filed Feb. 14, 2025
- Braidwell 2024 Q3 filed Nov. 14, 2024
- Braidwell 2024 Q2 filed Aug. 14, 2024
- Braidwell 2024 Q1 filed May 15, 2024
- Braidwell 2023 Q4 filed Feb. 14, 2024
- Braidwell 2023 Q3 filed Nov. 14, 2023
- Braidwell 2023 Q2 filed Aug. 14, 2023
- Braidwell 2023 Q1 filed May 15, 2023
- Braidwell 2022 Q4 filed Feb. 14, 2023